英国遗体捐献者白蛋白尿对肾移植利用及临床结局的影响:一项全国队列研究
该全国队列研究基于2016至2020年英国移植登记数据,分析遗体捐献者白蛋白尿(试纸≥2+)与肾脏利用及移植结局的关系。18%(1681/9309)的捐献者存在白蛋白尿,其肾脏被接受移植的比例较低(74% vs 82%;OR 0.70,95%CI 0.61–0.81)。中位随访2年,捐献者白蛋白尿与移植物失败(HR 0.91,95%CI 0.74–1.11)、移植物功能延迟恢复、患者生存或1年及3年eGFR均无关联。
要点
- 英国遗体捐献者中18%(1681/9309)存在试纸白蛋白尿(≥2+)。
- 白蛋白尿捐献者的肾脏被接受移植的比例较低(74% vs 82%;OR 0.70,95%CI 0.61–0.81)。
- 捐献者白蛋白尿与移植物失败、功能延迟恢复、患者生存及eGFR无关联。
核心结论
- 研究提示英国对试纸白蛋白尿遗体捐献者的肾脏利用存在犹豫,但未发现其与移植物生存或功能相关,可能具有扩大器官利用而不负面影响移植结局的潜力。
研究设计与样本
- 全国队列研究,纳入2016至2020年英国移植登记系统中成年遗体捐献者及肾移植受者。
主要发现
- 18%(1681/9309)的同意捐献者存在白蛋白尿(试纸≥2+)。
- 调整混杂因素后,白蛋白尿捐献者的肾脏被接受移植的比例为74%,无白蛋白尿者为82%(OR 0.70,95%CI 0.61–0.81)。
- 9834例肾移植中,1550例(16%)来自白蛋白尿捐献者。
- 中位随访2年,白蛋白尿捐献者移植物失败118/1550(8%),无白蛋白尿捐献者706/8284(9%);HR 0.91(95%CI 0.74–1.11)。
- 捐献者白蛋白尿与移植物功能延迟恢复、患者生存及1年或3年eGFR均无关联。
关键数值与推荐
- 捐献者白蛋白尿定义为试纸检测≥2+。
- 白蛋白尿捐献者肾脏被接受移植的OR为0.70(95%CI 0.61–0.81)。
- 移植物失败HR为0.91(95%CI 0.74–1.11)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Urinalysis is a standard component of potential deceased kidney donor assessment in the UK. The value of albuminuria as a biomarker for organ quality is uncertain. We examined the relationship between deceased donor albuminuria and kidney utilization, survival and function. METHODS: We performed a national cohort study on adult deceased donors and kidney transplant recipients between 2016 and 2020, using data from the UK Transplant Registry. We examined the influence of donor albuminuria, defined as ≥2+ on dipstick testing, on kidney utilization, early graft function, graft failure and estimated glomerular filtration rate (eGFR). RESULTS: Eighteen percent (1681/9309) of consented donors had albuminuria. After adjustment for confounders, kidneys from donors with albuminuria were less likely to be accepted for transplantation (74% versus 82%; odds ratio 0.70, 95% confidence interval 0.61 to 0.81). Of 9834 kidney transplants included in our study, 1550 (16%) came from donors with albuminuria. After a median follow-up of 2 years, 8% (118/1550) and 9% (706/8284) of transplants from donors with and without albuminuria failed, respectively. There was no association between donor albuminuria and graft failure (hazard ratio 0.91, 95% confidence interval 0.74 to 1.11). There was also no association with delayed graft function, patient survival or eGFR at 1 or 3 years. CONCLUSIONS: Our study suggests reluctance in the UK to utilize kidneys from deceased donors with dipstick albuminuria but no evidence of an association with graft survival or function. This may represent a potential to expand organ utilization without negatively impacting transplant outcomes.
引用
- Greenhall GHB, Robb M, Johnson RJ, et al. Utilization and clinical outcomes of kidney transplants from deceased donors with albuminuria in the UK: a national cohort study. Nephrol Dial Transplant. 2022. PMID: 36066902. doi:10.1093/ndt/gfac250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。